MedPath

Comparison of TAP Block and Intraperitoneal Ropivacaine for Pain Relief and Early Recovery After Laparoscopic Surgeries.

Recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2025/04/085339
Lead Sponsor
Mahatma Gandhi University of Medical Sciences and Technology
Brief Summary

This is a prospective, hospital based, comparative study to compare the efficacy of analgesia between Transversus Abdominis Plane Block (TAP) Block and Intraperitoneal mist instillation of Ropivacaine by assessing post-operative pain (static and dynamic) as per Numeric Rating Scale (NRS).

The secondary objective is to compare the meantime of the first dose of rescue analgesia in either group and the total supplementary analgesia required. Assessment of early recovery profile and ambulation as per ERAS protocol and to observe adverse effect related to study drug, if any.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
134
Inclusion Criteria
  • Patient posted for elective abdominal laparoscopic surgery needing general anaesthesia.
  • Patient with American Society of anaesthesiologists (ASA) Class I and II.
Exclusion Criteria
  • BMI more than 35 Patient with known or newly diagnosed coagulopathy Patient with history of drug allergy.
  • More than one attempt at T.A.P. blockade.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of analgesia between Transversus Abdominis Plane Block (TAP) Block and Intraperitoneal mist instillation of Ropivacaine by assessing post-operative pain (static and dynamic) as per Numeric Rating Scale (NRS).Postoperative pain score (NRS), SBP, DBP, MAP, HR and Oxygen Saturation will be recorded at 0 hours, 2 hours, 6 hours,12 hours and 24 hours after surgery.
Secondary Outcome Measures
NameTimeMethod
1. To compare the meantime of the first dose of rescue analgesia in either group & the total supplementary analgesia required.2. Assessment of early recovery profile & ambulation as per ERAS protocol.

Trial Locations

Locations (1)

Mahatma Gandhi University of Medical Sciences and Technology

🇮🇳

Jaipur, RAJASTHAN, India

Mahatma Gandhi University of Medical Sciences and Technology
🇮🇳Jaipur, RAJASTHAN, India
Ankur Sharma
Principal investigator
7023345035
ankursh@yandex.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.